Personalis Inc. Common Stock vs Symbotic Inc — how do they compare? Personalis Inc. Common Stock trades at $15.97 (market cap $1.70B), while Symbotic Inc trades at $38.87 (market cap $4.92B). The key difference: Symbotic Inc is far larger — about 2.9× Personalis Inc. Common Stock's market cap, and Personalis Inc. Common Stock is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Symbotic Inc for 24 Days on average.
| PSNL | SYM | |
|---|---|---|
Market Cap | $1.70B | $4.92B |
Volume | 3,262,398 | 1,694,503 |
Sector | Health | Industrials |
52-Week High | $18.38 | $87.30 |
52-Week Low | $5.04 | $37.90 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $1.52B | $3.18B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Symbotic (SYM) is trading at $37.54, down 8.19% over the past 24 hours, with technical indicators showing bearish momentum. The company reported negative net income of -$16.94 million in 2025 despite revenue of $2.25 billion, though 2026 projections show potential profitability improvement. Analyst sentiment is mixed with 61% buy ratings but recent earnings misses have created uncertainty. The stock faces significant customer concentration risk with Walmart accounting for 85% of revenue, though the company maintains a substantial $22.5 billion backlog.
The outlook remains challenging with elevated valuation metrics (P/E 947.5) and recent earnings disappointments, but long-term growth potential exists through warehouse automation demand. Key risks include customer concentration, execution challenges, and competitive pressures. The consensus price target of $55.50 suggests 48% upside potential if the company can achieve projected profitability improvements and backlog conversion.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →